Home> Industry News >R&D >Main Body

  • Industry News

Bristol-Myers advances new LAG-3 drug relatlimab to fight PD-1 resistance

2017-09-13 09:57
fiercebiotech
Read:76 Favorite  0
  Share
You may interest
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top